Foxchart.com
Artivion, Inc. (CRY)
17.88  0.25 (1.42%)  01-24 00:00
Open: 17.64
High: 18.22
Low: 17.49
Volume: 257,460
Market Cap: 725(M)
PE Ratio: 425.71
Exchange: New York Stock Exchange
Industry: Medical - Devices
Sector: Healthcare
Technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell buy
Resistance 2: 28.66
Resistance 1: 24.54
Pivot price: 23.76
Support 1: 20.18
Support 2: 17.49
52w High: 32.34
52w Low: 16.61
Zoom in Zoom out
Draw lines
Horizontal lines
Parallel lines
Fibonacci lines
Remove studies
Shot and share

Artivion Inc., established in 1984 and based in Kennesaw, Georgia, functions globally as a manufacturer, processor, and distributor of both medical devices and implantable human tissues. Previously known as CryoLife, Inc., the company underwent a rebranding to Artivion Inc. in January 2022. Artivion caters to a wide array of clients, including physicians, hospitals, various healthcare facilities, and specialized surgeons in cardiac, vascular, thoracic, and general fields. Their comprehensive product portfolio features BioGlue, a polymer formulated from bovine blood protein for use in cardiac, vascular, pulmonary, and general surgical procedures. They also provide the On-X line of prosthetic aortic and mitral heart valves, alongside the On-X ascending aortic prosthesis. Artivion extends its services to include cardiac preservation and offers PhotoFix, a bovine pericardial patch, as well as the E-vita OPEN PLUS and E-vita OPEN NEO hybrid stent graft systems. The company is a prominent supplier of specialized stent grafts designed for numerous aortic and arterial conditions. These include the E-xtra DESIGN ENGINEERING products for aortic vascular diseases, E-nside as an off-the-shelf option for thoraco-abdominal disease, E-vita THORACIC 3G for endovascular treatment of thoracic aortic aneurysms, E-nya for minimally invasive repair of descending aorta lesions, E-ventus BX for renal and pelvic arteries, E-liac for aneurysmal iliac arteries and their side branches, and E-tegra for abdominal aortic aneurysms. Further offerings encompass synthetic vascular grafts for open aortic and peripheral surgeries, PerClot (an absorbable powdered hemostat), and cardiac laser therapy equipment such as the SolarGen 2100s Console. They also provide CryoVein and CryoArtery vascular preservation services, CarbonAid CO2 diffusion catheters, Chord-X ePTFE sutures for mitral chordal replacement, and ascyrus medical dissection stents. Additionally, Artivion provides pyrolytic carbon coating services to other manufacturers in the medical device industry.

Financials
EPS 0.000
Book Value 0.000
PEG Ratio 0.00
Gross Profit 0.000
Profit Margin (%) 0.00
Operating Margin (%) 0.00
Return on Assets (ttm) 0.0
Return on Equity (ttm) 0.0
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
×
Share on Facebook Tweet this page

Foxchart:  |  United States  |  Canada  |  United Kingdom  |  Australia  |  New Zealand  |  Singapore  |  India

©Foxchart.com All Rights Reserved. Foxchart.com | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither Foxchart.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX